NLRP3 and type 2 diabetes mellitus: Vandanmagsar et al. reported that in obese patients with type 2 diabetes mellitus, weight loss resulted in reduced inflammation in subcutaneous adipose tissue and a simultaneous decrease NLRP3 inflammasome expression39.